Patients with central nervous system lymphoma undergoing thiotepa, busulfan, and cyclophosphamide-conditioned autologous stem cell transplantation are at a higher risk for DNA virus infections than patients with systemic non-Hodgkin lymphoma receiving traditional conditioning Meeting Abstract


Authors: Scordo, M.; Morjaria, S. M.; Bhatia, A.; Littmann, E. R.; Maloy, M.; DeAngelis, L.; Giralt, S. A.; Taur, Y.; Sauter, C. S.
Abstract Title: Patients with central nervous system lymphoma undergoing thiotepa, busulfan, and cyclophosphamide-conditioned autologous stem cell transplantation are at a higher risk for DNA virus infections than patients with systemic non-Hodgkin lymphoma receiving traditional conditioning
Meeting Title: 59th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 130
Issue: Suppl. 1
Meeting Dates: 2017 Dec 9-12
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2017-12-07
Language: English
ACCESSION: WOS:000432419704120
PROVIDER: wos
DOI: 10.1182/blood.V130.Suppl_1.4528.4528
Notes: Meeting Abstract: 4528 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Sergio Andres Giralt
    1051 Giralt
  2. Craig Steven Sauter
    334 Sauter
  3. Ying Taur
    147 Taur
  4. Molly Anna Maloy
    269 Maloy
  5. Michael Scordo
    366 Scordo
  6. Ankush Bhatia
    18 Bhatia